Stem cell transplant without toxic preparation successfully treats genetic disease
An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic busulfan chemotherapy or radiation, a Phase I clinical trial has shown.
Jul 22, 2025
1
1027









